Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADUCANUMAB-AVWA for Cognitive disorder: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where ADUCANUMAB-AVWA was used for Cognitive disorder.

Most Reported Side Effects for ADUCANUMAB-AVWA

Side Effect Reports % Deaths Hosp.
Amyloid related imaging abnormality-oedema/effusion 90 21.9% 4 8
Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits 61 14.8% 2 4
Headache 33 8.0% 1 6
Confusional state 32 7.8% 3 7
Cerebral haemorrhage 26 6.3% 1 5
Dementia alzheimer's type 22 5.4% 2 7
Fall 21 5.1% 4 9
Amyloid related imaging abnormalities 17 4.1% 0 3
Dizziness 15 3.7% 0 2
Brain oedema 14 3.4% 1 5
Cognitive disorder 13 3.2% 2 0
Seizure 13 3.2% 4 6
Superficial siderosis of central nervous system 13 3.2% 0 0
Death 12 2.9% 12 2
Memory impairment 12 2.9% 0 1

Other Indications for ADUCANUMAB-AVWA

Dementia alzheimer's type (341) Product used for unknown indication (58)

Other Drugs Used for Cognitive disorder

DONEPEZIL (350) LECANEMAB-IRMB (282) QUETIAPINE (141) RIVASTIGMINE (137) MEMANTINE (135) RISPERIDONE (112) DONANEMAB-AZBT (96) PIMAVANSERIN (92) DALFAMPRIDINE (59) CLOZAPINE (47)

Related Pages

ADUCANUMAB-AVWA Full Profile All Cognitive disorder Drugs ADUCANUMAB-AVWA Demographics ADUCANUMAB-AVWA Timeline